AlphaStocks
4.5
Weak

Amphastar Pharmaceuticals, Inc. (AMPH)

Health Care / Pharmaceuticals

S&P SmallCap 600

$20.23

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#720out of 1127 in Health Care

Is Amphastar Pharmaceuticals, Inc. a Good Investment in 2026?

Amphastar Pharmaceuticals, Inc. (AMPH) scores 4.5 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Amphastar Pharmaceuticals, Inc. as Attractive (6/9). The Greenblatt Magic Formula model is the least favorable, rating it Attractive. Amphastar Pharmaceuticals, Inc. ranks #720 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E9.9ROE15.0Market Cap975.4M

Valuation

Trades at 10x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Attractive

22% below fair value

Lynch

Attractive

PEG 0.6 · Fast Grower

Greenblatt

Attractive

Top half (rank 46%)

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. (AMPH) a good investment?
Based on AlphaStocks' composite analysis, Amphastar Pharmaceuticals, Inc. (AMPH) scores 4.5 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trades at 10x earnings — near sector median of 25x.
What is Amphastar Pharmaceuticals, Inc.'s Piotroski F-Score?
Amphastar Pharmaceuticals, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is AMPH overvalued or undervalued?
A precise fair value estimate is not available for AMPH. Trades at 10x earnings — near sector median of 25x.
How does AMPH compare to other Health Care stocks?
Amphastar Pharmaceuticals, Inc. ranks #720 out of 1127 stocks in the Health Care sector, placing it in the top 64% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about AMPH?
AlphaStocks evaluates AMPH using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Attractive; Lynch: Attractive; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.5/10.

Similar Stocks

PARRFTIAZN

Compare AMPH with

AMPH vs PARRAMPH vs FTIAMPH vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer